132 related articles for article (PubMed ID: 31455274)
21. Shifting the Cancer Screening Paradigm: The Rising Potential of Blood-Based Multi-Cancer Early Detection Tests.
Brito-Rocha T; Constâncio V; Henrique R; Jerónimo C
Cells; 2023 Mar; 12(6):. PubMed ID: 36980276
[TBL] [Abstract][Full Text] [Related]
22. Human circulating small non-coding RNA signature as a non-invasive biomarker in clinical diagnosis of acute myeloid leukaemia.
Xia L; Guo H; Wu X; Xu Y; Zhao P; Yan B; Zeng Y; He Y; Chen D; Gale RP; Zhang Y; Zhang X
Theranostics; 2023; 13(4):1289-1301. PubMed ID: 36923527
[No Abstract] [Full Text] [Related]
23. Construction of a serum diagnostic signature based on m5C-related miRNAs for cancer detection.
Tang F; Liu Y; Sun Y; Xiong Y; Gu Y; Zhou J; Ouyang Y; Zhang S
Front Endocrinol (Lausanne); 2023; 14():1099703. PubMed ID: 36777349
[TBL] [Abstract][Full Text] [Related]
24. m
Zhang B; Chen Z; Tao B; Yi C; Lin Z; Li Y; Shao W; Lin J; Chen J
Mol Cancer; 2021 Dec; 20(1):170. PubMed ID: 34930277
[TBL] [Abstract][Full Text] [Related]
25. Development and validation of a serum microRNA biomarker panel for detecting gastric cancer in a high-risk population.
So JBY; Kapoor R; Zhu F; Koh C; Zhou L; Zou R; Tang YC; Goo PCK; Rha SY; Chung HC; Yoong J; Yap CT; Rao J; Chia CK; Tsao S; Shabbir A; Lee J; Lam KP; Hartman M; Yong WP; Too HP; Yeoh KG
Gut; 2021 May; 70(5):829-837. PubMed ID: 33028667
[TBL] [Abstract][Full Text] [Related]
26. Circulating microRNAs: Next-generation Cancer Detection.
Matsuzaki J; Ochiya T
Keio J Med; 2020 Dec; 69(4):88-96. PubMed ID: 32404538
[TBL] [Abstract][Full Text] [Related]
27. m
Zhang B; Wu Q; Li B; Wang D; Wang L; Zhou YL
Mol Cancer; 2020 Mar; 19(1):53. PubMed ID: 32164750
[TBL] [Abstract][Full Text] [Related]
28. Level of N6-Methyladenosine in Peripheral Blood RNA: A Novel Predictive Biomarker for Gastric Cancer.
Ge L; Zhang N; Chen Z; Song J; Wu Y; Li Z; Chen F; Wu J; Li D; Li J; Wang C; Wang H; Wang J
Clin Chem; 2020 Feb; 66(2):342-351. PubMed ID: 32040577
[TBL] [Abstract][Full Text] [Related]
29. Descriptive and Functional Genomics in Neonatal Respiratory Distress Syndrome: From Lung Development to Targeted Therapies.
Anciuc-Crauciuc M; Cucerea MC; Tripon F; Crauciuc GA; Bănescu CV
Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203821
[TBL] [Abstract][Full Text] [Related]
30. miRNA Expression Profiles in Ovarian Endometriosis and Two Types of Ovarian Cancer-Endometriosis-Associated Ovarian Cancer and High-Grade Ovarian Cancer.
Szubert M; Nowak-Glück A; Domańska-Senderowska D; Szymańska B; Sowa P; Rycerz A; Wilczyński JR
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139300
[TBL] [Abstract][Full Text] [Related]
31. Network approach in liquidomics landscape.
Santini D; Botticelli A; Galvano A; Iuliani M; Incorvaia L; Gristina V; Taffon C; Foderaro S; Paccagnella E; Simonetti S; Fazio F; Scagnoli S; Pomati G; Pantano F; Perrone G; De Falco E; Russo A; Spinelli GP
J Exp Clin Cancer Res; 2023 Aug; 42(1):193. PubMed ID: 37542343
[TBL] [Abstract][Full Text] [Related]
32. Review on the Role of Salivary Biomarkers in the Diagnosis of Mild Traumatic Brain Injury and Post-Concussion Syndrome.
Mavroudis I; Petridis F; Balmus IM; Ciobica A; Gorgan DL; Luca AC
Diagnostics (Basel); 2023 Apr; 13(8):. PubMed ID: 37189468
[TBL] [Abstract][Full Text] [Related]
33. Enhancing clinical potential of liquid biopsy through a multi-omic approach: A systematic review.
Di Sario G; Rossella V; Famulari ES; Maurizio A; Lazarevic D; Giannese F; Felici C
Front Genet; 2023; 14():1152470. PubMed ID: 37077538
[TBL] [Abstract][Full Text] [Related]
34. Plasma microRNAs as potential biomarkers in early Alzheimer disease expression.
Peña-Bautista C; Tarazona-Sánchez A; Braza-Boils A; Balaguer A; Ferré-González L; Cañada-Martínez AJ; Baquero M; Cháfer-Pericás C
Sci Rep; 2022 Sep; 12(1):15589. PubMed ID: 36114255
[TBL] [Abstract][Full Text] [Related]
35. Circulating microRNAs as the Potential Diagnostic and Prognostic Biomarkers for Nasopharyngeal Carcinoma.
Le TAH; Lao TD
Genes (Basel); 2022 Jun; 13(7):. PubMed ID: 35885944
[TBL] [Abstract][Full Text] [Related]
36. Saliva Based Liquid Biopsies in Head and Neck Cancer: How Far Are We From the Clinic?
Patel A; Patel S; Patel P; Tanavde V
Front Oncol; 2022; 12():828434. PubMed ID: 35387114
[TBL] [Abstract][Full Text] [Related]
37. Albendazole reduces hepatic inflammation and endoplasmic reticulum-stress in a mouse model of chronic Echinococcus multilocularis infection.
Weingartner M; Stücheli S; Jebbawi F; Gottstein B; Beldi G; Lundström-Stadelmann B; Wang J; Odermatt A
PLoS Negl Trop Dis; 2022 Jan; 16(1):e0009192. PubMed ID: 35030165
[TBL] [Abstract][Full Text] [Related]
38. Multiple microRNA signature panel as promising potential for diagnosis and prognosis of head and neck cancer.
Subha ST; Chin JW; Cheah YK; Mohtarrudin N; Saidi HI
Mol Biol Rep; 2022 Feb; 49(2):1501-1511. PubMed ID: 34837627
[TBL] [Abstract][Full Text] [Related]
39. Beyond liquid biopsy: Toward non-invasive assays for distanced cancer diagnostics in pandemics.
Ferrara F; Zoupanou S; Primiceri E; Ali Z; Chiriacò MS
Biosens Bioelectron; 2022 Jan; 196():113698. PubMed ID: 34688113
[TBL] [Abstract][Full Text] [Related]
40. A Clinical Update on the Prognostic Effect of microRNA Biomarkers for Survival Outcome in Nasopharyngeal Carcinoma: A Systematic Review and Meta-Analysis.
Shaw P; Senthilnathan R; Krishnan S; Suresh D; Shetty S; Muthukaliannan GK; Mani RR; Sivanandy P; Chandramoorthy HCK; Gupta MM; Baxi S; Jayaraj R
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503179
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
